Hellobaby Surrogacy Inc – Trademark Portfolio
Entity Type: 03
Hellobaby Surrogacy Inc holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 2 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include HELLOBABY SURROGACY. The owner is based in CHINO HILLS, CA.
16809 BERRYESSA CT
CHINO HILLS, CA 91709
Showing of trademarks Trademarks
Trademark Classifications
Hellobaby Surrogacy Inc's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Advertising; business management; business administration; office functions
Legal services; security services for the protection of property and individuals
Frequently Asked Questions
How many trademarks does Hellobaby Surrogacy Inc have?
Hellobaby Surrogacy Inc has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.
What trademark classes does Hellobaby Surrogacy Inc file in?
Hellobaby Surrogacy Inc files trademarks across 3 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 35 (Advertising & Business), Class 45 (Legal & Security Services). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are Hellobaby Surrogacy Inc's most well-known trademarks?
Hellobaby Surrogacy Inc's registered trademark portfolio includes well-known marks such as HELLOBABY SURROGACY. These are among 1 currently registered trademark in the portfolio.
What is Hellobaby Surrogacy Inc's trademark registration success rate?
Hellobaby Surrogacy Inc has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.